首页 > 最新文献

Iranian Journal of Pathology最新文献

英文 中文
Pathological Examination of the Placenta in COVID-19-Positive Mothers: A Short Communication. covid -19阳性母亲胎盘病理检查:简短交流
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.30699/IJP.2023.551018.2860
Sedigheh Hantoushzadeh, Roya Saeednejad, Mamak Shariat, Raheleh Moradi

Background & objective: It was declared that COVID-19 might be more severe in symptomatic pregnant patients. This study was conducted to examine the pathological indices of the placenta in pregnant women who were diagnosed with COVID-19.

Methods: A total of 20 COVID-19-positive mothers were enrolled in this study. Detailed placental pathology findings were compared between subjects based on the history of abortion or occurrence of preterm delivery, hypertension, and diabetes.

Results and conclusion: Intervillositis was the most frequent abnormality of the placenta. There was also a significant association between abortion history and maternal vascular malperfusion (MVM; P=0.02). The placental abnormalities were found to be increased in women with COVID-19, regardless of maternal comorbidities. Further studies are needed to compare the placental pathology between COVID-19-positive women and healthy women.

背景与目的:有症状的妊娠患者中COVID-19可能更为严重。本研究旨在检测新冠肺炎确诊孕妇胎盘病理指标。方法:选取20例covid -19阳性母亲为研究对象。根据流产史、早产史、高血压史和糖尿病史,对受试者的详细胎盘病理结果进行比较。结果与结论:绒毛间炎是胎盘最常见的异常。流产史与母体血管灌注不良(MVM;P = 0.02)。无论母体合并症如何,发现COVID-19女性胎盘异常增加。需要进一步的研究来比较covid -19阳性妇女和健康妇女的胎盘病理。
{"title":"Pathological Examination of the Placenta in COVID-19-Positive Mothers: A Short Communication.","authors":"Sedigheh Hantoushzadeh,&nbsp;Roya Saeednejad,&nbsp;Mamak Shariat,&nbsp;Raheleh Moradi","doi":"10.30699/IJP.2023.551018.2860","DOIUrl":"https://doi.org/10.30699/IJP.2023.551018.2860","url":null,"abstract":"<p><strong>Background & objective: </strong>It was declared that COVID-19 might be more severe in symptomatic pregnant patients. This study was conducted to examine the pathological indices of the placenta in pregnant women who were diagnosed with COVID-19.</p><p><strong>Methods: </strong>A total of 20 COVID-19-positive mothers were enrolled in this study. Detailed placental pathology findings were compared between subjects based on the history of abortion or occurrence of preterm delivery, hypertension, and diabetes.</p><p><strong>Results and conclusion: </strong>Intervillositis was the most frequent abnormality of the placenta. There was also a significant association between abortion history and maternal vascular malperfusion (MVM; <i>P</i>=0.02). The placental abnormalities were found to be increased in women with COVID-19, regardless of maternal comorbidities. Further studies are needed to compare the placental pathology between COVID-19-positive women and healthy women.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 2","pages":"217-220"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439745/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10039808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MMP-9 and CCR7 as Possible Predictors of Lymph Node Metastasis in Laryngeal Squamous Cell Carcinoma. MMP-9和CCR7可能是喉鳞癌淋巴结转移的预测因子。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.30699/ijp.2023.563014.2986
Lisnawati Rachmadi, Ela Laelasari, Yayi Dwina Billianti Susanto, Kusmardi Kusmardi

Background & objective: The expression of matrix metalloproteinase-9 (MMP-9) and chemokine receptor 7 (CCR7) is significantly associated with tumor invasion and metastasis. Little is known regarding the potential of these markers in predicting cancer metastasis in Laryngeal Squamous Cell Carcinoma (LSCC). Therefore, this study aimed to dissect the potential of these markers in predicting the lymph node metastasis in LSCC patients.

Methods: Sixty tissue samples were obtained from the patients diagnosed pathologically with LSCC who underwent partial or total laryngectomy. The expression of MMP-9 and CCR7 was measured using the immunohistochemistry staining in the tissue samples of LSCC patients. The ROC (receiver operating characteristic) curve was used to determine the most significant cut-off points of expression according to the highest sensitivity and specificity of both the markers to predict the lymph node metastasis in LSCC. Then, the relationship between the clinicopathology features and the expression of MMP-9 and CCR7 was evaluated.

Results: The expression of both MMP-9 and CCR7 was significantly correlated with the lymph node metastasis in LSCC (P<0.001). Furthermore, CCR7 expression exhibited the highest prediction accuracy (AUC 95.7%) and sensitivity (100%) in predicting the lymph node metastasis in LSCC compared to that of MMP-9 (AUC 92.9%, sensitivity 90%). We also found that patients with larger tumor size (> 4 cm) had significantly higher expression of MMP-9 and CCR7 (P<0.002 and P<0.001, respectively). The Elevated expression level of CCR7 statistically correlated with higher MMP-9 expression (P<0.001).

Conclusion: MMP-9 and CCR7 might be beneficial as predictors of lymph node metastasis in LSCC patients.

背景与目的:基质金属蛋白酶-9 (MMP-9)和趋化因子受体7 (CCR7)的表达与肿瘤侵袭转移密切相关。关于这些标志物在预测喉鳞癌(LSCC)转移中的潜力,我们知之甚少。因此,本研究旨在探讨这些标志物在预测LSCC患者淋巴结转移中的潜力。方法:从病理诊断为喉鳞癌并行部分或全喉切除术的患者中获得60份组织样本。采用免疫组化染色法检测LSCC患者组织样本中MMP-9和CCR7的表达。根据两种标志物预测LSCC淋巴结转移的最高敏感性和特异性,采用ROC (receiver operating characteristic)曲线确定最显著的表达截止点。然后评估临床病理特征与MMP-9和CCR7表达的关系。结果:MMP-9和CCR7的表达与LSCC淋巴结转移有显著相关性(p4cm)。结论:MMP-9和CCR7可能是LSCC患者淋巴结转移的有益预测因子。
{"title":"MMP-9 and CCR7 as Possible Predictors of Lymph Node Metastasis in Laryngeal Squamous Cell Carcinoma.","authors":"Lisnawati Rachmadi,&nbsp;Ela Laelasari,&nbsp;Yayi Dwina Billianti Susanto,&nbsp;Kusmardi Kusmardi","doi":"10.30699/ijp.2023.563014.2986","DOIUrl":"https://doi.org/10.30699/ijp.2023.563014.2986","url":null,"abstract":"<p><strong>Background & objective: </strong>The expression of matrix metalloproteinase-9 (MMP-9) and chemokine receptor 7 (CCR7) is significantly associated with tumor invasion and metastasis. Little is known regarding the potential of these markers in predicting cancer metastasis in Laryngeal Squamous Cell Carcinoma (LSCC). Therefore, this study aimed to dissect the potential of these markers in predicting the lymph node metastasis in LSCC patients.</p><p><strong>Methods: </strong>Sixty tissue samples were obtained from the patients diagnosed pathologically with LSCC who underwent partial or total laryngectomy. The expression of MMP-9 and CCR7 was measured using the immunohistochemistry staining in the tissue samples of LSCC patients. The ROC (receiver operating characteristic) curve was used to determine the most significant cut-off points of expression according to the highest sensitivity and specificity of both the markers to predict the lymph node metastasis in LSCC. Then, the relationship between the clinicopathology features and the expression of MMP-9 and CCR7 was evaluated.</p><p><strong>Results: </strong>The expression of both MMP-9 and CCR7 was significantly correlated with the lymph node metastasis in LSCC (<i>P</i><0.001). Furthermore, CCR7 expression exhibited the highest prediction accuracy (AUC 95.7%) and sensitivity (100%) in predicting the lymph node metastasis in LSCC compared to that of MMP-9 (AUC 92.9%, sensitivity 90%). We also found that patients with larger tumor size (> 4 cm) had significantly higher expression of MMP-9 and CCR7 (<i>P</i><0.002 and <i>P</i><0.001, respectively). The Elevated expression level of CCR7 statistically correlated with higher MMP-9 expression (<i>P</i><0.001).</p><p><strong>Conclusion: </strong>MMP-9 and CCR7 might be beneficial as predictors of lymph node metastasis in LSCC patients.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 2","pages":"156-164"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439748/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10048573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Cytokeratin-7 and Cytokeratin-19 Expression Relationship with Gleason Score in Prostatic Adenocarcinoma. 前列腺腺癌细胞角蛋白-7和细胞角蛋白-19表达与Gleason评分的关系
Q3 Medicine Pub Date : 2023-01-01 Epub Date: 2023-08-18 DOI: 10.30699/IJP.2023.2002657.3116
Masood Soltanipur, Mohammadreza Jalali Nadoushan, Hossein Yarmohammadi

Background & objective: Prostatic adenocarcinoma (PAC) is one of the most common tumors worldwide. Immunohistochemical expression of cytokeratins has been evaluated in the diagnosis and prognosis of tumors. The aim of the present study is the evaluation of Cytokeratin-7 (Ck-7) and Cytokeratin-19 (Ck-19) expression and its relationship with Gleason score in patients with PAC.

Methods: In this cross-sectional study, 78 samples from 78 patients with PAC referred to Mostafa Khomeini Hospital were gathered. Samples were immunohistochemically stained by Ck-7 and Ck-19 markers. The percentage of each marker in tumor cells was determined, and its relationship with Gleason scores and Gleason grade groups was analysed by SPSS version 24.

Results: The expression of Ck-7 and Ck-19 were seen in 37.2% and 82.1% of samples, respectively. The mean of Ck-7 expression in tumor cells was 4.98%±7.19 (ranged 0 to 26%), while the mean of Ck-19 expression was 41.02%±23.36 (ranged 0 to 78%). There was no relationship between Ck-7 expression with Gleason scores and Gleason grade groups. However, Ck-19 expression was increased in higher Gleason scores and Gleason grade groups (P<0.001). No relationship was found between age and Ck-7 (P=0.309) and Ck-19 (P=0.375).

Conclusion: The Ck-7 expression in PAC samples is weak and focal and had no relationship with the Gleason scores and Gleason grade groups. However, Ck-19 expression in PAC was high and was associated with tumor dedifferentiation of samples. There was no relationship between the expression of both markers with the patient's age.

Ck-7
{"title":"Evaluation of Cytokeratin-7 and Cytokeratin-19 Expression Relationship with Gleason Score in Prostatic Adenocarcinoma.","authors":"Masood Soltanipur, Mohammadreza Jalali Nadoushan, Hossein Yarmohammadi","doi":"10.30699/IJP.2023.2002657.3116","DOIUrl":"10.30699/IJP.2023.2002657.3116","url":null,"abstract":"<p><strong>Background & objective: </strong>Prostatic adenocarcinoma (PAC) is one of the most common tumors worldwide. Immunohistochemical expression of cytokeratins has been evaluated in the diagnosis and prognosis of tumors. The aim of the present study is the evaluation of Cytokeratin-7 (Ck-7) and Cytokeratin-19 (Ck-19) expression and its relationship with Gleason score in patients with PAC.</p><p><strong>Methods: </strong>In this cross-sectional study, 78 samples from 78 patients with PAC referred to Mostafa Khomeini Hospital were gathered. Samples were immunohistochemically stained by Ck-7 and Ck-19 markers. The percentage of each marker in tumor cells was determined, and its relationship with Gleason scores and Gleason grade groups was analysed by SPSS version 24.</p><p><strong>Results: </strong>The expression of Ck-7 and Ck-19 were seen in 37.2% and 82.1% of samples, respectively. The mean of Ck-7 expression in tumor cells was 4.98%±7.19 (ranged 0 to 26%), while the mean of Ck-19 expression was 41.02%±23.36 (ranged 0 to 78%). There was no relationship between Ck-7 expression with Gleason scores and Gleason grade groups. However, Ck-19 expression was increased in higher Gleason scores and Gleason grade groups (<i>P</i><0.001). No relationship was found between age and Ck-7 (<i>P</i>=0.309) and Ck-19 (<i>P</i>=0.375).</p><p><strong>Conclusion: </strong>The Ck-7 expression in PAC samples is weak and focal and had no relationship with the Gleason scores and Gleason grade groups. However, Ck-19 expression in PAC was high and was associated with tumor dedifferentiation of samples. There was no relationship between the expression of both markers with the patient's age.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":" ","pages":"363-369"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46643475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Different Isoforms of PML-RARA Chimeric Protein in Patients with Acute Promyelocytic Leukemia: Survival Analysis per Demographic Characteristics, Clinicohematological Parameters, and Cytogenetic Findings. 急性早幼粒细胞白血病患者中 PML-RARA 嵌合蛋白的不同异构体:按人口统计学特征、临床血液学参数和细胞遗传学结果的生存率分析
Q3 Medicine Pub Date : 2023-01-01 Epub Date: 2023-12-15 DOI: 10.30699/IJP.2023.20007229.3145
Sarah Siahbani, Akbar Safaei, Masoumeh Faghih, Marzieh Hosseini, Afsaneh Fendereski, Behnaz Valibeigi, Ahmad Monabati

Background & objective: Acute Promyelocytic Leukemia (APL) is a medical emergency with potentially fatal complications. APL primarily results from a chromosomal translocation (t(15;17)(q22;q21)), leading to the formation of the PML-RARA fusion gene with three possible isoforms. This study aims to investigate the characteristics of Iranian APL patients, the distribution of PML-RARA isoforms, and survival analysis.

Methods: We included 145 consecutive eligible patients in this study. Data were collected through archived documents and phone inquiries, following consent. Subsequently, we analyzed the data using SPSS software version 26.0.

Results: We examined 75 men and 70 women, with a mean age of 34 years (range: 2-78 years). Besides t(15;17) (q22;q21), 45.6% had other chromosomal abnormalities. The prevalence of bcr1 and bcr3 isoforms was 73% and 27%, respectively. bcr3 correlated with higher white blood cell (WBC) counts, additional chromosomal abnormalities, and faster Complete Hematologic Response (CHR). Early death occurred in approximately 36% of all patients. The mean overall survival time was 73.5 months, with 120-month survival rates of 53.8% for all patients and 83.9% for those who achieved CHR. Univariate analysis identified old age, relapse, lower platelet (PLT) counts, higher WBC counts, and leukocytosis as survival risk factors. However, in multivariate analysis, only old age and higher WBC counts were identified as adverse prognostic factors.

Conclusion: In Iranian APL patients, bcr1 predominates, while bcr3 correlates with higher WBC counts, high-risk categorization, additional chromosomal abnormalities, and faster CHR. Survival is negatively impacted by old age, relapse, lower PLT counts, higher WBC counts, and leukocytosis.

背景与目的:急性早幼粒细胞白血病(APL)是一种具有潜在致命并发症的急症。APL 主要由染色体易位(t(15;17)(q22;q21))引起,导致 PML-RARA 融合基因的形成,并可能有三种同工酶。本研究旨在调查伊朗 APL 患者的特征、PML-RARA 同工型的分布和生存分析:本研究共纳入 145 名符合条件的连续患者。在征得同意后,我们通过存档文件和电话询问收集数据。随后,我们使用 SPSS 软件 26.0 版对数据进行了分析:我们对 75 名男性和 70 名女性进行了检查,他们的平均年龄为 34 岁(范围:2-78 岁)。除了t(15;17) (q22;q21)外,45.6%的患者有其他染色体异常。bcr3与较高的白细胞(WBC)计数、其他染色体异常和较快的完全血液学反应(CHR)相关。所有患者中约有 36% 出现早期死亡。平均总存活时间为 73.5 个月,所有患者的 120 个月存活率为 53.8%,达到 CHR 的患者存活率为 83.9%。单变量分析发现,高龄、复发、较低的血小板(PLT)计数、较高的白细胞计数和白细胞增多是生存风险因素。然而,在多变量分析中,只有高龄和较高的白细胞计数被确定为不良预后因素:结论:在伊朗 APL 患者中,bcr1 占主导地位,而 bcr3 与较高的白细胞计数、高危分类、额外的染色体异常和较快的 CHR 相关。高龄、复发、较低的 PLT 计数、较高的白细胞计数和白细胞增多会对患者的生存产生负面影响。
{"title":"Different Isoforms of PML-RARA Chimeric Protein in Patients with Acute Promyelocytic Leukemia: Survival Analysis per Demographic Characteristics, Clinicohematological Parameters, and Cytogenetic Findings.","authors":"Sarah Siahbani, Akbar Safaei, Masoumeh Faghih, Marzieh Hosseini, Afsaneh Fendereski, Behnaz Valibeigi, Ahmad Monabati","doi":"10.30699/IJP.2023.20007229.3145","DOIUrl":"10.30699/IJP.2023.20007229.3145","url":null,"abstract":"<p><strong>Background & objective: </strong>Acute Promyelocytic Leukemia (APL) is a medical emergency with potentially fatal complications. APL primarily results from a chromosomal translocation (t(15;17)(q22;q21)), leading to the formation of the PML-RARA fusion gene with three possible isoforms. This study aims to investigate the characteristics of Iranian APL patients, the distribution of PML-RARA isoforms, and survival analysis.</p><p><strong>Methods: </strong>We included 145 consecutive eligible patients in this study. Data were collected through archived documents and phone inquiries, following consent. Subsequently, we analyzed the data using SPSS software version 26.0.</p><p><strong>Results: </strong>We examined 75 men and 70 women, with a mean age of 34 years (range: 2-78 years). Besides t(15;17) (q22;q21), 45.6% had other chromosomal abnormalities. The prevalence of bcr1 and bcr3 isoforms was 73% and 27%, respectively. bcr3 correlated with higher white blood cell (WBC) counts, additional chromosomal abnormalities, and faster Complete Hematologic Response (CHR). Early death occurred in approximately 36% of all patients. The mean overall survival time was 73.5 months, with 120-month survival rates of 53.8% for all patients and 83.9% for those who achieved CHR. Univariate analysis identified old age, relapse, lower platelet (PLT) counts, higher WBC counts, and leukocytosis as survival risk factors. However, in multivariate analysis, only old age and higher WBC counts were identified as adverse prognostic factors.</p><p><strong>Conclusion: </strong>In Iranian APL patients, bcr1 predominates, while bcr3 correlates with higher WBC counts, high-risk categorization, additional chromosomal abnormalities, and faster CHR. Survival is negatively impacted by old age, relapse, lower PLT counts, higher WBC counts, and leukocytosis.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 4","pages":"456-475"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646742/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138799861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Salivary Gland Tumors in Iran: A Systematic Review of 2870 Cases Based on the New WHO Classification. 伊朗唾液腺肿瘤:基于WHO新分类的2870例系统回顾
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.30699/IJP.2023.559121.2942
Sahar Assar, Sepideh Assar, Heidar-Ali Mardanifard, Zohreh Jaafari-Ashkavandi

Background & objective: There is no consensus on the prevalence of salivary gland tumors (SGTs) in Iran. Thus, we systematically reviewed the literature about the prevalence of SGTs in Iran and applied the last world health organization (WHO) classification.

Methods: The systematic literature search was performed in EMBASE, Scopus, PubMed MEDLINE, Google Scholar, Scientific Information Database (SID), and Magiran; we searched for "salivary gland," "tumor," "prevalence," and "Iran" until 1 March 2021. The studies included were written in the English and Farsi languages. The weighted mean prevalence of SGTs was calculated as prevalence (%) * (N/the sum of all N). We used the unpaired Two-sample T-test to compare the weighted means.

Results: A total of 17 studies, including 2870 patients, were selected for the data synthesis. The weighted mean prevalence of benign and malignant tumors was 66% (95% CI: 59-73) and 34% (95% CI: 27-41), respectively. The patients' mean age was reported in 10 out of the 17 studies. The weighted mean age of the patients was 40 (95% CI: 37-42) and 49 (95% CI: 43-55) years for benign and malignant tumors, respectively (P=0.01). Pleomorphic adenoma (PA), followed by Warthin's tumor (WT), was the most prevalent benign tumor. Moreover, the most common malignant tumors were mucoepidermoid carcinoma (MEC) and adenoid cystic carcinoma (AdCC).

Conclusion: More than one-third of SGTs in Iran were malignant, which is higher than the reports from Middle Eastern countries. Information about risk factors and the burden of SGTs in Iran is insufficient. Thus, further well-designed longitudinal studies are warranted.

背景与目的:关于伊朗唾液腺肿瘤(sgt)的患病率尚无共识。因此,我们系统地回顾了有关伊朗sgt患病率的文献,并应用了世界卫生组织(WHO)的最新分类。方法:在EMBASE、Scopus、PubMed MEDLINE、Google Scholar、Scientific Information Database (SID)、Magiran等数据库中进行系统文献检索;我们搜索了“唾液腺”、“肿瘤”、“患病率”和“伊朗”,直到2021年3月1日。所包括的研究是用英语和波斯语写成的。sgt的加权平均患病率计算为患病率(%)* (N/所有N的和)。我们使用未配对的双样本t检验来比较加权平均值。结果:共纳入17项研究,共纳入2870例患者。良性和恶性肿瘤的加权平均患病率分别为66% (95% CI: 59-73)和34% (95% CI: 27-41)。17项研究中有10项报告了患者的平均年龄。良性肿瘤加权平均年龄为40岁(95% CI: 37 ~ 42),恶性肿瘤加权平均年龄为49岁(95% CI: 43 ~ 55) (P=0.01)。多形性腺瘤(PA)是最常见的良性肿瘤,其次为Warthin's tumor (WT)。此外,最常见的恶性肿瘤是粘液表皮样癌(MEC)和腺样囊性癌(AdCC)。结论:伊朗三分之一以上的sgt为恶性,高于中东国家的报告。关于伊朗sgt的风险因素和负担的信息不足。因此,进一步精心设计的纵向研究是必要的。
{"title":"Salivary Gland Tumors in Iran: A Systematic Review of 2870 Cases Based on the New WHO Classification.","authors":"Sahar Assar,&nbsp;Sepideh Assar,&nbsp;Heidar-Ali Mardanifard,&nbsp;Zohreh Jaafari-Ashkavandi","doi":"10.30699/IJP.2023.559121.2942","DOIUrl":"https://doi.org/10.30699/IJP.2023.559121.2942","url":null,"abstract":"<p><strong>Background & objective: </strong>There is no consensus on the prevalence of salivary gland tumors (SGTs) in Iran. Thus, we systematically reviewed the literature about the prevalence of SGTs in Iran and applied the last world health organization (WHO) classification.</p><p><strong>Methods: </strong>The systematic literature search was performed in EMBASE, Scopus, PubMed MEDLINE, Google Scholar, Scientific Information Database (SID), and Magiran; we searched for \"salivary gland,\" \"tumor,\" \"prevalence,\" and \"Iran\" until 1 March 2021. The studies included were written in the English and Farsi languages. The weighted mean prevalence of SGTs was calculated as prevalence (%) * (N/the sum of all N). We used the unpaired Two-sample T-test to compare the weighted means.</p><p><strong>Results: </strong>A total of 17 studies, including 2870 patients, were selected for the data synthesis. The weighted mean prevalence of benign and malignant tumors was 66% (95% CI: 59-73) and 34% (95% CI: 27-41), respectively. The patients' mean age was reported in 10 out of the 17 studies. The weighted mean age of the patients was 40 (95% CI: 37-42) and 49 (95% CI: 43-55) years for benign and malignant tumors, respectively (<i>P</i>=0.01). Pleomorphic adenoma (PA), followed by Warthin's tumor (WT), was the most prevalent benign tumor. Moreover, the most common malignant tumors were mucoepidermoid carcinoma (MEC) and adenoid cystic carcinoma (AdCC).</p><p><strong>Conclusion: </strong>More than one-third of SGTs in Iran were malignant, which is higher than the reports from Middle Eastern countries. Information about risk factors and the burden of SGTs in Iran is insufficient. Thus, further well-designed longitudinal studies are warranted.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 1","pages":"1-11"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293605/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9791912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Implication and Survival Outcomes of Perioperative Blood Transfusion on Urological Malignancies Undergoing Radical Surgical Intervention. 泌尿外科恶性肿瘤根治性手术围手术期输血的预后意义和生存结果。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.30699/ijp.2023.553040.2887
Sujata Mallick, Mahasweta Mallik, Puskar Shyam Chowdhury

Background & objective: Background and objective: Perioperative blood transfusion (PBT) during radical urological surgeries has been associated with an increased incidence of complications. The present study analyzes the outcome of perioperative blood transfusion (PBT) and the prognostic implications after radical surgeries on patients with malignant urological tumors.

Methods: Our retrospective study included 792 cases of partial or radical nephrectomy /cystectomy/prostatectomy surgeries for kidney/bladder/ prostate carcinoma from 2012 to 2022. Data on preoperative, intraoperative, and pathological parameters were evaluated. PBT was taken as a period of transfusion of allogenic RBC during/preoperative/postoperative surgeries. The effect of PBT on oncological parameters like recurrence-free survival (RFS), overall survival (OS), and cancer-free survival (CSS) was compared using univariate cox regression analysis (Odds ratio, Hazard ratio).

Results: PBT was applied on 124 (20.6%) patients of nephrectomy, 54 (46.5%) patients of cystectomy, and 23 (31%) patients of prostatectomy. The baseline characteristics of the cohort study found symptomatic patients with older age and other co-morbidities to be transfusion-dependent. Also, the patients undergoing radical operations with more blood loss and advanced tumor stage were more likely to receive PBT. PBT was significantly associated with survival outcomes (P<0.05) in nephrectomy and cystectomy cases but independent of association in prostatectomy cases.

Conclusion: The result of this study concludes that in nephrectomy and cystectomy operations, PBT had a significant association with cancer recurrence and mortality; however, in prostatectomy cases, no significant correlation was noted. Thus, proper criteria to prevent the unnecessary use of PBT and more defined parameters for transfusion are needed to improve postoperative survival. Autologous transfusion should be considered more frequently. However, more extensive studies and randomized trials are needed in this area.

背景与目的:背景与目的:泌尿外科根治性手术围手术期输血(PBT)与并发症发生率增加有关。本研究分析泌尿系统恶性肿瘤根治性手术后围手术期输血(PBT)的预后。方法:回顾性研究2012年至2022年792例肾/膀胱/前列腺癌部分或根治性肾/膀胱/前列腺切除术。评估术前、术中及病理参数的数据。PBT是指在术前和术后输注同种异体红细胞的一段时间。采用单因素cox回归分析(Odds ratio, Hazard ratio)比较PBT对肿瘤参数如无复发生存期(RFS)、总生存期(OS)和无癌生存期(CSS)的影响。结果:PBT应用于肾切除术124例(20.6%),膀胱切除术54例(46.5%),前列腺切除术23例(31%)。队列研究的基线特征发现有症状的老年患者和其他合并症是输血依赖的。同时,接受根治性手术且出血量大、肿瘤分期晚期的患者更容易接受PBT。PBT与生存结局显著相关(p结论:本研究结果表明,在肾切除术和膀胱切除术中,PBT与肿瘤复发和死亡率显著相关;然而,在前列腺切除术病例中,没有明显的相关性。因此,需要适当的标准来防止不必要的PBT使用和更明确的输血参数,以提高术后生存率。应考虑更频繁地进行自体输血。然而,这一领域还需要更广泛的研究和随机试验。
{"title":"Prognostic Implication and Survival Outcomes of Perioperative Blood Transfusion on Urological Malignancies Undergoing Radical Surgical Intervention.","authors":"Sujata Mallick,&nbsp;Mahasweta Mallik,&nbsp;Puskar Shyam Chowdhury","doi":"10.30699/ijp.2023.553040.2887","DOIUrl":"https://doi.org/10.30699/ijp.2023.553040.2887","url":null,"abstract":"<p><strong>Background & objective: </strong>Background and objective: Perioperative blood transfusion (PBT) during radical urological surgeries has been associated with an increased incidence of complications. The present study analyzes the outcome of perioperative blood transfusion (PBT) and the prognostic implications after radical surgeries on patients with malignant urological tumors.</p><p><strong>Methods: </strong>Our retrospective study included 792 cases of partial or radical nephrectomy /cystectomy/prostatectomy surgeries for kidney/bladder/ prostate carcinoma from 2012 to 2022. Data on preoperative, intraoperative, and pathological parameters were evaluated. PBT was taken as a period of transfusion of allogenic RBC during/preoperative/postoperative surgeries. The effect of PBT on oncological parameters like recurrence-free survival (RFS), overall survival (OS), and cancer-free survival (CSS) was compared using univariate cox regression analysis (Odds ratio, Hazard ratio).</p><p><strong>Results: </strong>PBT was applied on 124 (20.6%) patients of nephrectomy, 54 (46.5%) patients of cystectomy, and 23 (31%) patients of prostatectomy. The baseline characteristics of the cohort study found symptomatic patients with older age and other co-morbidities to be transfusion-dependent. Also, the patients undergoing radical operations with more blood loss and advanced tumor stage were more likely to receive PBT. PBT was significantly associated with survival outcomes (<i>P</i><0.05) in nephrectomy and cystectomy cases but independent of association in prostatectomy cases.</p><p><strong>Conclusion: </strong>The result of this study concludes that in nephrectomy and cystectomy operations, PBT had a significant association with cancer recurrence and mortality; however, in prostatectomy cases, no significant correlation was noted. Thus, proper criteria to prevent the unnecessary use of PBT and more defined parameters for transfusion are needed to improve postoperative survival. Autologous transfusion should be considered more frequently. However, more extensive studies and randomized trials are needed in this area.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 1","pages":"33-48"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293603/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9736727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Preliminary Sequence Analysis of the Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) Carboxy-Terminal Region in Cervical and Ovarian Cancers. 爱泼斯坦-巴尔病毒核抗原1 (EBNA1)羧基末端在宫颈癌和卵巢癌中的初步序列分析
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.30699/ijp.2023.551761.2872
Fatemeh Hosseini Tabatabaie, Seyed Younes Hosseini, Seyed Mohammad Ali Hashemi, Akbar Safaie, Jamal Sarvari
Background & Objective: Epstein-Barr virus nuclear antigen-1 (EBNA1) is one of the most important proteins of Epstein-Barr virus (EBV) that might be mutated in various related cancers. The purpose of this study was to compare EBNA1 mutations in the C-terminal region between patients with cervical and ovarian cancer and healthy individuals. Methods: As test and control groups, 18 EBV-positive paraffin-embedded samples of cervical and ovarian cancer and 10 age- and gender-matched healthy volunteers who did not have cancer but were EBV-positive were both used. Utilizing a commercial DNA extraction kit, total DNA was extracted following deparaffinization. The entire C-terminal region of the EBNA1 sequence was amplified using an in-house nested PCR. Phylogenetic analysis and Sanger sequencing were used to analyze the sequences using MEGA 7 software and through NJ method. Results: Sequence analysis revealed that the P-Ala subtype of EBNA1 was present in all samples. In two and one samples, respectively, of cervical cancer patients, the mutations A1887G and G1891A were found. The G1595T mutation was also detected in four sequences taken from ovarian cancer patients. No statistically significant difference could be found between the frequency of mutations in patients and controls (P>0.05). No known amino acid substitutions were found in the USP7-binding region and the DBD/DD domain. Conclusion: The findings showed that P-Ala is the predominant EBV subtype across all samples. Additionally, as the sequence of EBNA1's C-terminal region is so stable, it's possible that it had little impact on the pathogenesis of ovarian and cervical malignancies. It is advised to conduct additional research to verify these findings.
背景与目的:eb病毒核抗原-1 (EBNA1)是eb病毒(EBV)最重要的蛋白之一,可能在多种相关肿瘤中发生突变。本研究的目的是比较宫颈癌和卵巢癌患者与健康个体c端区域的EBNA1突变。方法:选取18例ebv阳性的宫颈癌和卵巢癌石蜡包埋标本,以及10例年龄和性别匹配的未患癌症但ebv阳性的健康志愿者作为实验组和对照组。利用商业DNA提取试剂盒,脱蜡后提取总DNA。利用内部巢式PCR扩增EBNA1序列的整个c端区域。采用mega7软件和NJ法对序列进行系统发育分析和Sanger测序。结果:序列分析显示,所有样本均存在P-Ala亚型EBNA1。在宫颈癌患者的两个和一个样本中分别发现了突变A1887G和G1891A。在取自卵巢癌患者的四个序列中也检测到G1595T突变。患者与对照组的突变频率差异无统计学意义(P>0.05)。在usp7结合区和DBD/DD结构域未发现已知的氨基酸取代。结论:在所有样本中P-Ala是主要的EBV亚型。此外,由于EBNA1的c端序列非常稳定,可能对卵巢和宫颈恶性肿瘤的发病机制影响不大。建议进行进一步的研究来验证这些发现。
{"title":"A Preliminary Sequence Analysis of the Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) Carboxy-Terminal Region in Cervical and Ovarian Cancers.","authors":"Fatemeh Hosseini Tabatabaie,&nbsp;Seyed Younes Hosseini,&nbsp;Seyed Mohammad Ali Hashemi,&nbsp;Akbar Safaie,&nbsp;Jamal Sarvari","doi":"10.30699/ijp.2023.551761.2872","DOIUrl":"https://doi.org/10.30699/ijp.2023.551761.2872","url":null,"abstract":"Background & Objective: Epstein-Barr virus nuclear antigen-1 (EBNA1) is one of the most important proteins of Epstein-Barr virus (EBV) that might be mutated in various related cancers. The purpose of this study was to compare EBNA1 mutations in the C-terminal region between patients with cervical and ovarian cancer and healthy individuals. Methods: As test and control groups, 18 EBV-positive paraffin-embedded samples of cervical and ovarian cancer and 10 age- and gender-matched healthy volunteers who did not have cancer but were EBV-positive were both used. Utilizing a commercial DNA extraction kit, total DNA was extracted following deparaffinization. The entire C-terminal region of the EBNA1 sequence was amplified using an in-house nested PCR. Phylogenetic analysis and Sanger sequencing were used to analyze the sequences using MEGA 7 software and through NJ method. Results: Sequence analysis revealed that the P-Ala subtype of EBNA1 was present in all samples. In two and one samples, respectively, of cervical cancer patients, the mutations A1887G and G1891A were found. The G1595T mutation was also detected in four sequences taken from ovarian cancer patients. No statistically significant difference could be found between the frequency of mutations in patients and controls (P>0.05). No known amino acid substitutions were found in the USP7-binding region and the DBD/DD domain. Conclusion: The findings showed that P-Ala is the predominant EBV subtype across all samples. Additionally, as the sequence of EBNA1's C-terminal region is so stable, it's possible that it had little impact on the pathogenesis of ovarian and cervical malignancies. It is advised to conduct additional research to verify these findings.","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 1","pages":"24-32"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293606/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9739401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Higher Risk of Chronic Hepatitis E Virus Infection in Patients with Human Immunodeficiency Virus-1: An Iranian Cross-sectional Study. 人类免疫缺陷病毒1型患者感染慢性戊型肝炎病毒的风险较高:伊朗横断面研究
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.30699/IJP.2023.551657.2870
Mohammad Javad Zahedi, Sara Shafieipour, Mohammad Mahdi Hayatbakhsh Abassi, Nader Pourjamali, Mohsen Nakhaie, Javad Charostad, Mohammad Rezaei Zadeh Rukerd, Mohammad Mehdi Lashkarizadeh, Fatemeh Karami Robati, Azam Dehghani, Yunes Jahani, Seyed Ali Mohammad Arabzadeh, Hamid Reza Mollaei, Ebrahim Ranjbar

Background & objective: Occurrence of Hepatitis E Virus (HEV) infection may be common in Human Immunodeficiency Virus (HIV-1) patients and may lead to chronic infection as well as cirrhosis. We intended to determine the incidence of HEV infection among HIV-1 patients compared to individuals without HIV-1 infection.

Methods: In our cross-sectional study, 87 HIV-1-positive patients were compared to 93 healthy individuals in Kerman, Iran. Plasma and peripheral blood mononuclear cells (PBMCs) were obtained from all the participants. Plasma samples were evaluated for HEV IgM and IgG using the ELISA kit. Then, reverse transcriptase-nested polymerase chain reaction (RT-nested PCR) was used in RNA extractions from PBMCs to check for the presence of HEV RNA.

Results: Among the subjects examined in our study, 61 (70.1%) and 71 (77.4%) out of patients with HIV-1 infection and healthy individuals were male, respectively. The average ages of patients with HIV-1 and the control group were 40.2 years and 39.9 years, respectively. No discernible differences were found between the two groups based on IgM and IgG seropositivity against the HEV. However, HEV-RNA was found in 8% of patients with HIV-1 and 1.1% of HIV-1-negative individuals (P=0.03). There was also an association between the HEV genome and anti-HEV and anti-HCV antibodies in HIV-1-positive patients (P=0.02 and P=0.014, respectively).

Conclusion: HEV infection may be more common in HIV-1 patients and may develop a chronic infection in immunocompromised individuals. Molecular-based HEV diagnostic tests, including RT-PCR assays, should be performed in HIV-1 patients with unknown impaired liver function tests.

背景与目的:戊型肝炎病毒(HEV)感染在人类免疫缺陷病毒(HIV-1)患者中可能很常见,并可能导致慢性感染和肝硬化。我们打算确定HIV-1患者与未感染HIV-1的个体相比HEV感染的发生率。方法:在我们的横断面研究中,将伊朗Kerman的87例hiv -1阳性患者与93名健康个体进行比较。所有受试者均取血浆和外周血单个核细胞(PBMCs)。使用ELISA试剂盒检测血浆样本的HEV IgM和IgG。然后,利用逆转录巢式聚合酶链反应(rt -巢式PCR)从pbmc中提取RNA,以检测HEV RNA的存在。结果:在我们的研究对象中,HIV-1感染患者和健康个体中男性分别为61例(70.1%)和71例(77.4%)。HIV-1患者和对照组的平均年龄分别为40.2岁和39.9岁。基于对HEV的IgM和IgG血清阳性,两组之间没有发现明显的差异。然而,8%的HIV-1患者和1.1%的HIV-1阴性个体中发现了HEV-RNA (P=0.03)。hiv -1阳性患者的HEV基因组与抗HEV和抗hcv抗体之间也存在关联(P=0.02和P=0.014)。结论:HEV感染可能在HIV-1患者中更为常见,并可能在免疫功能低下的个体中发展为慢性感染。在肝功能检测结果未知的HIV-1患者中,应进行基于分子的HEV诊断检测,包括RT-PCR检测。
{"title":"Higher Risk of Chronic Hepatitis E Virus Infection in Patients with Human Immunodeficiency Virus-1: An Iranian Cross-sectional Study.","authors":"Mohammad Javad Zahedi,&nbsp;Sara Shafieipour,&nbsp;Mohammad Mahdi Hayatbakhsh Abassi,&nbsp;Nader Pourjamali,&nbsp;Mohsen Nakhaie,&nbsp;Javad Charostad,&nbsp;Mohammad Rezaei Zadeh Rukerd,&nbsp;Mohammad Mehdi Lashkarizadeh,&nbsp;Fatemeh Karami Robati,&nbsp;Azam Dehghani,&nbsp;Yunes Jahani,&nbsp;Seyed Ali Mohammad Arabzadeh,&nbsp;Hamid Reza Mollaei,&nbsp;Ebrahim Ranjbar","doi":"10.30699/IJP.2023.551657.2870","DOIUrl":"https://doi.org/10.30699/IJP.2023.551657.2870","url":null,"abstract":"<p><strong>Background & objective: </strong>Occurrence of Hepatitis E Virus (HEV) infection may be common in Human Immunodeficiency Virus (HIV-1) patients and may lead to chronic infection as well as cirrhosis. We intended to determine the incidence of HEV infection among HIV-1 patients compared to individuals without HIV-1 infection.</p><p><strong>Methods: </strong>In our cross-sectional study, 87 HIV-1-positive patients were compared to 93 healthy individuals in Kerman, Iran. Plasma and peripheral blood mononuclear cells (PBMCs) were obtained from all the participants. Plasma samples were evaluated for HEV IgM and IgG using the ELISA kit. Then, reverse transcriptase-nested polymerase chain reaction (RT-nested PCR) was used in RNA extractions from PBMCs to check for the presence of HEV RNA.</p><p><strong>Results: </strong>Among the subjects examined in our study, 61 (70.1%) and 71 (77.4%) out of patients with HIV-1 infection and healthy individuals were male, respectively. The average ages of patients with HIV-1 and the control group were 40.2 years and 39.9 years, respectively. No discernible differences were found between the two groups based on IgM and IgG seropositivity against the HEV. However, HEV-RNA was found in 8% of patients with HIV-1 and 1.1% of HIV-1-negative individuals (P=0.03). There was also an association between the HEV genome and anti-HEV and anti-HCV antibodies in HIV-1-positive patients (P=0.02 and P=0.014, respectively).</p><p><strong>Conclusion: </strong>HEV infection may be more common in HIV-1 patients and may develop a chronic infection in immunocompromised individuals. Molecular-based HEV diagnostic tests, including RT-PCR assays, should be performed in HIV-1 patients with unknown impaired liver function tests.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 2","pages":"125-133"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439753/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10048574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship Between Leptin Receptor Expression and Endometrial Carcinoma; A Case-Control Study. 瘦素受体表达与子宫内膜癌的关系病例对照研究。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.30699/ijp.2023.1972584.3017
Mojtaba Sehhat, Zahra Moshfegh Arani, Niyusha Lajevardi Hosseini, Malek Reiesifar, Fahimeh Abdi Abyaneh, Zarichehr Vakili

Background & objective: Endometrial carcinoma is one of the most common malignancies in women in developed countries and the fourth malignancy in Iranian women. Therefore, the identification of its causative factors is essential for the prevention, diagnosis, and treatment. This study was aimed to compare the leptin receptor (Ob-R) expression in the endometrial carcinoma cases and non-carcinoma samples.

Methods: In this case-control study, 89 samples (including 45 carcinoma and 44 non-carcinoma samples) were examined. The carcinomatous samples were selected by the census method and others were selected with random method. The data were obtained from histopathologic diagnosis, immunohistochemistry (negative, positive and intensity of immunoreactivity), age, history of diabetes, and hypertension. Ob-R expression was compared in the studied groups using Chi-square, Fisher tests and Multivariate logistic regression analysis. In all tests the level of significance was set at 0.05. The SPSS 26 was used for data analysis.

Results: The frequency of high levels of leptin receptors in the patients with endometrial carcinoma was significantly higher compared to the control group (57.8% vs. 2.3%) (P<0.05). Adjusting the effects of age, history of diabetes mellitus (DM) and hypertension (HTN) revealed that the positive-receptor group had 37.75 (95% CI; 5.18-275.04) odds of having endometrial carcinoma (P<0.001).

Conclusion: The leptin receptor may be a risk factor for the endometrial carcinoma among women tested in Kashan. Based on these results, leptin receptor might be considered as a potential biomarker for screening the endometrial carcinoma or targeting the therapeutic purposes.

背景与目的:子宫内膜癌是发达国家妇女最常见的恶性肿瘤之一,也是伊朗妇女的第四大恶性肿瘤。因此,确定其致病因素对预防、诊断和治疗至关重要。本研究旨在比较瘦素受体(Ob-R)在子宫内膜癌和非子宫内膜癌中的表达。方法:病例对照研究89例,其中癌45例,非癌44例。癌变样本采用普查法,其他样本采用随机抽样法。数据来自组织病理学诊断、免疫组织化学(阴性、阳性和免疫反应强度)、年龄、糖尿病史和高血压。采用卡方检验、Fisher检验和多元logistic回归分析比较各研究组Ob-R的表达。在所有检验中,显著性水平设为0.05。采用SPSS 26进行数据分析。结果:高水平瘦素受体在子宫内膜癌患者中的频率明显高于对照组(57.8% vs. 2.3%)(结论:瘦素受体可能是卡尚地区妇女子宫内膜癌的一个危险因素。基于这些结果,瘦素受体可能被认为是子宫内膜癌筛查或靶向治疗的潜在生物标志物。
{"title":"The Relationship Between Leptin Receptor Expression and Endometrial Carcinoma; A Case-Control Study.","authors":"Mojtaba Sehhat,&nbsp;Zahra Moshfegh Arani,&nbsp;Niyusha Lajevardi Hosseini,&nbsp;Malek Reiesifar,&nbsp;Fahimeh Abdi Abyaneh,&nbsp;Zarichehr Vakili","doi":"10.30699/ijp.2023.1972584.3017","DOIUrl":"https://doi.org/10.30699/ijp.2023.1972584.3017","url":null,"abstract":"<p><strong>Background & objective: </strong>Endometrial carcinoma is one of the most common malignancies in women in developed countries and the four<sup>th</sup> malignancy in Iranian women. Therefore, the identification of its causative factors is essential for the prevention, diagnosis, and treatment. This study was aimed to compare the leptin receptor (Ob-R) expression in the endometrial carcinoma cases and non-carcinoma samples.</p><p><strong>Methods: </strong>In this case-control study, 89 samples (including 45 carcinoma and 44 non-carcinoma samples) were examined. The carcinomatous samples were selected by the census method and others were selected with random method. The data were obtained from histopathologic diagnosis, immunohistochemistry (negative, positive and intensity of immunoreactivity), age, history of diabetes, and hypertension. Ob-R expression was compared in the studied groups using Chi-square, Fisher tests and Multivariate logistic regression analysis. In all tests the level of significance was set at 0.05. The SPSS 26 was used for data analysis.</p><p><strong>Results: </strong>The frequency of high levels of leptin receptors in the patients with endometrial carcinoma was significantly higher compared to the control group (57.8% vs. 2.3%) (<i>P</i><0.05). Adjusting the effects of age, history of diabetes mellitus (DM) and hypertension (HTN) revealed that the positive-receptor group had 37.75 (95% CI; 5.18-275.04) odds of having endometrial carcinoma (<i>P</i><0.001).</p><p><strong>Conclusion: </strong>The leptin receptor may be a risk factor for the endometrial carcinoma among women tested in Kashan. Based on these results, leptin receptor might be considered as a potential biomarker for screening the endometrial carcinoma or targeting the therapeutic purposes.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"18 2","pages":"173-179"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439756/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10424257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of Parvovirus B19, Cytomegalovirus, Herpes Simplex Virus Types 1 and 2, Human Papillomavirus Types 16 and 18 in Papillary Thyroid Carcinoma. 甲状腺乳头状癌中细小病毒B19、巨细胞病毒、单纯疱疹病毒1型和2型、人乳头瘤病毒16型和18型的研究
Q3 Medicine Pub Date : 2023-01-01 Epub Date: 2023-07-16 DOI: 10.30699/IJP.2023.1982745.3032
Fakhriyeh Kalavari, Parin Tanzifi, Tahereh Yousefi, Maryam Lotfi, Elham Nazar

Background & objective: Viral infections are associated with the pathogenesis and progression of human malignancies. Several studies have suggested the role of viral infections in papillary thyroid carcinoma (PTC). However, the results are still conflicting, and the potential role of viruses in PTC tumorigenesis remains to be elucidated. In the present study, we aimed to investigate the presence of parvovirus B19, cytomegalovirus (CMV), herpes simplex virus types 1 and 2 (HSV-1/HSV-2), and human papillomavirus (HPV) types 16 and 18 in PTC.

Methods: In this cross-sectional study, paraffin-embedded tissue blocks of 40 patients with PTC were used. Tissue blocks were studied for the presence of the virus genome using real-time polymerase chain reaction (PCR).

Results: Of the 40 patients with PTC, there was 1 positive case of HPV (2.5%), while 6 cases were positive for parvovirus B19. HSV and CMV DNAs were not detected in any cases.

Conclusion: Correlations among HSV, CMV, and PTC are unexpected in our patient population. But parvovirus B19 and, to a lesser extent, HPV DNA genomes were detected in PTC using real-time PCR.

摘要
{"title":"Investigation of Parvovirus B19, Cytomegalovirus, Herpes Simplex Virus Types 1 and 2, Human Papillomavirus Types 16 and 18 in Papillary Thyroid Carcinoma.","authors":"Fakhriyeh Kalavari, Parin Tanzifi, Tahereh Yousefi, Maryam Lotfi, Elham Nazar","doi":"10.30699/IJP.2023.1982745.3032","DOIUrl":"10.30699/IJP.2023.1982745.3032","url":null,"abstract":"<p><strong>Background & objective: </strong>Viral infections are associated with the pathogenesis and progression of human malignancies. Several studies have suggested the role of viral infections in papillary thyroid carcinoma (PTC). However, the results are still conflicting, and the potential role of viruses in PTC tumorigenesis remains to be elucidated. In the present study, we aimed to investigate the presence of parvovirus B19, cytomegalovirus (CMV), herpes simplex virus types 1 and 2 (HSV-1/HSV-2), and human papillomavirus (HPV) types 16 and 18 in PTC.</p><p><strong>Methods: </strong>In this cross-sectional study, paraffin-embedded tissue blocks of 40 patients with PTC were used. Tissue blocks were studied for the presence of the virus genome using real-time polymerase chain reaction (PCR).</p><p><strong>Results: </strong>Of the 40 patients with PTC, there was 1 positive case of HPV (2.5%), while 6 cases were positive for parvovirus B19. HSV and CMV DNAs were not detected in any cases.</p><p><strong>Conclusion: </strong>Correlations among HSV, CMV, and PTC are unexpected in our patient population. But parvovirus B19 and, to a lesser extent, HPV DNA genomes were detected in PTC using real-time PCR.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":" ","pages":"370-375"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628384/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44996865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Iranian Journal of Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1